Profile – Winnie Henry, Lived Experience Researcher
Winnie Henry is a retired Psychotherapist, support co-production research projects, as a person with lived experience of dementia.
All posts by Dementia Researcher
NIHR ARC East Midlands – ‘Lunch & Learn’ Training Series
Welcome to the NIHR ARC East Midlands ‘Lunch & Learn’ series, recordings of 20+ training sessions, covering a range of topics to expand your research skills.
Profile – Mike Parish, Lived Experience Researcher
Mike Parish is a lived experience researcher, Post-Carer for his husband / Director LGBTQ+ Dementia Advisory Group CIC passionate about public involvement
Lewy Body Dementia
Alzheimer’s Society Doctoral Training Centre for Lewy body dementia led by Professor John-Paul Taylor at Newcastle University.
Integrated Dementia Care
Alzheimer’s Society Doctoral Training Centre for Integrated Dementia Care led by Professor Claudia Cooper and Professor Nathan Davies at Queen Mary’s University London.
Vascular and Immune Contributors to Dementia
Alzheimer’s Society Doctoral Training Centre for Vascular and Immune Contributors to Dementia led by Professor Stuart Allan at University of Manchester.
Profile – David Ross, Lived Experience Researcher
David Ross is a lived experience researcher, patient and public involvement contributor and supporter of co-produced dementia research.
Toolkit for Sharing Clinical Trial Results with Participants
Sharing Clinical Trials results with trial participants builds trust, show respect, and help participants feel valued. The MRC SHOW RESPECT framework can help
Blog – Poetic Tales from Dementia Wards
Dr Ayokunmi Ojebode unveils the emotional depth and dignity of those living with dementia through the powerful lens of poetry – Read or Listen
Golnaz Atefi’s 1,000km Skating Journey for Dementia Research
Interview with Golnaz Atefi about her unique plans to roller skate 1000km in 30 days across Europe, in support of research and World Alzheimer’s Month.
Lecanemab recieves NICE rejection
NICE draft recommendation says Lecanemab benefits are too small to support approval after looking at cost and clinical trials evidence
Lecanemab recieves UK MHRA approval
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a product licence for lecanemab (Leqembi) for use in the early stages of Alzheimer’s